Journal of Law and the Biosciences Robin Feldman Published: 07 December 2018 Abstract Presenting the first comprehensive study of evergreening, this article examines the extent to which evergreening behavior—which can be defined as artificially extending the protection cliff—may contribute to the problem. The author analyses all drugs on the market between 2005 and 2015, combing […]

Continue Reading

The most effective way to reduce drug prices is by spurring more competition. Sadly, big pharma invests heavily in blocking competition and abusing the patent system to continue charging any price they want. In fact, drug makers are ringing in 2019 by raising the price of hundreds of drugs already on the market. That’s not innovation. That’s price gouging.

Continue Reading

  COALITION AGAINST PATENT ABUSE (CAPA) FORMS TO LOWER DRUG PRICES BY ENDING BRAND NAME DRUG PATENT ABUSE Consumer groups, patients, free market advocacy organizations and health care industry associations band together to advocate for policies to end overextended brand drug monopolies Washington, DC (January 16, 2019) Healthcare providers, free market advocates, consumer groups, patient […]

Continue Reading